Skip to main content
. 2014 Jul 2;91(1):77–80. doi: 10.4269/ajtmh.14-0100

Figure 1.

Figure 1.

Performance of the CareStart RDT compared with the spectrophotometric method at G6PD activity levels from ≤ 0.5 to ≥ 5.6 U/g hemoglobin. The sensitivity and specificity as well as the positive and negative predictive values of the CareStart RDT to classify severely, moderately, or mildly deficient individuals from the sample population are presented with respect to the G6PD activity level (units per gram hemoglobin [Hgb]) measured by the spectrophotometric assay.